CD80 and neoplasm: MDSCs obtained from tumors and spleens of tumor bearing mice treated with IL-12 up-regulated the surface markers of macrophages (F4/80 and MHC II) and DCs (CD80 and CD86) suggesting differentiation into more mature, less immunosuppressive forms.